首页|胰岛素经皮给药研究进展

胰岛素经皮给药研究进展

扫码查看
治疗糖尿病的主要方法是皮下注射胰岛素,但长期注射胰岛素会导致疼痛、针头恐惧症和依从性降低以及感染风险。与皮下注射相比,经皮给药以预定和可控的速度将胰岛素输送到皮肤屏障,是一种非侵入性的胰岛素输送方法。然而,肽类和其他生物大分子的透皮给药受到皮肤最外层构成的屏障限制,增加药物渗透性并为药物运输增加额外驱动力是经皮给药的主要挑战。本文针对胰岛素经皮给药的问题主要介绍两种胰岛素经皮给药递送技术,分别是微针方法和药物载体。
Research Progress of Percutaneous Insulin Administration
The primary treatment for diabetes involves subcutaneous insulin injections;however,long-term administration of insulin through injections can result in pain,needle phobia,reduced adherence,and an increased risk of infection.In contrast to subcutaneous in-jection,percutaneous delivery provides a non-invasive method of delivering insulin to the skin barrier at a predetermined and controlled rate.Nevertheless,transdermal drug delivery of peptides and other biomacromolecules is hindered by barriers formed by the outermost layer of the skin.Enhancing drug permeability and introducing additional driving forces for drug delivery pose significant challenges in transdermal drug administration.This paper introduces two approaches-microneedle technique and drug carriers-aimed at addressing the issue of percutaneous insulin delivery.

insulinpercutaneousmicroneedledrug carrier

郝乘仪、陶家乐、韦伟、杨润琦、王瑛

展开 >

吉林医药学院药学院,吉林吉林 132013

胰岛素 经皮 微针 药物载体

2024

吉林医药学院学报
吉林医药学院

吉林医药学院学报

影响因子:0.459
ISSN:1673-2995
年,卷(期):2024.45(6)